########################################
# Program: needle
# Rundate: Wed 30 May 2018 11:54:13
# Commandline: needle
#    -outfile /Users/teresatavella/Documents/models_new/seqid60_90/gb_WP_009887863.1_ARO_3003357_Clostridium_3u6b_A/needle.txt
#    -asequence /Users/teresatavella/Documents/models_new/seqid60_90/gb_WP_009887863.1_ARO_3003357_Clostridium_3u6b_A/gb_WP_009887863.1_ARO_3003357_Clostridium_difficile_EF-Tu_mutants_conferring_resistance_to_elfamycin__Clostridium_difficile.fa
#    -bsequence /Users/teresatavella/Documents/models_new/seqid60_90/gb_WP_009887863.1_ARO_3003357_Clostridium_3u6b_A/3u6b_A.fa
#    -gapopen 10
#    -gapextend 0.5
# Align_format: srspair
# Report_file: /Users/teresatavella/Documents/models_new/seqid60_90/gb_WP_009887863.1_ARO_3003357_Clostridium_3u6b_A/needle.txt
########################################

#=======================================
#
# Aligned_sequences: 2
# 1: gb_WP_009887863.1_ARO_3003357_Clostridium_difficile_EF-Tu_mutants_conferring_resistance_to_elfamycin__Clostridium_difficile
# 2: 3u6b_A_mol_protein_length_394__Elongation_factor_Tu_1
# Matrix: EBLOSUM62
# Gap_penalty: 10.0
# Extend_penalty: 0.5
#
# Length: 397
# Identity:     279/397 (70.3%)
# Similarity:   322/397 (81.1%)
# Gaps:          28/397 ( 7.1%)
# Score: 1456.5
# 
#
#=======================================

gb_WP_0098878      1 MAKAKYERTKPHVNIGTIGHVDHGKTTLTAAITKTLYDRYQLGEAVDFAN     50
                          :||||||||:||||||||||||||||||..|...|          
3u6b_A_mol_pr      1 -----FERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTY----------     35

gb_WP_0098878     51 IDKAPEERERGITISTAHVEYETPNRHYAHVDCPGHADYVKNMITGAAQM    100
                            ..|||||:|:||||:||.|||||||||||||||||||||||||
3u6b_A_mol_pr     36 -------GGRGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQM     78

gb_WP_0098878    101 DGAILVCSATDGPMPQTREHILLSRQVGVPYIVVFLNKCDMVDDEELLEL    150
                     ||||||.:|||||||||||||||.||||||||:|||||||||||||||||
3u6b_A_mol_pr     79 DGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLEL    128

gb_WP_0098878    151 VEMEVRDLLTEYDFPGDDTPIVRGSALMALEDPKSEWGDKIVELFEQIDE    200
                     ||||||:||::||||||||||||||||.|||. .:||..||:||...:|.
3u6b_A_mol_pr    129 VEMEVRELLSQYDFPGDDTPIVRGSALKALEG-DAEWEAKILELAGFLDS    177

gb_WP_0098878    201 YIPAPERDTDKPFLMPVEDVFSITGRGTVATGRVERGVLKVQDEVELVGL    250
                     |||.|||..|||||:|:||||||    ||.|||||||::||.:|||:||:
3u6b_A_mol_pr    178 YIPEPERAIDKPFLLPIEDVFSI----TVVTGRVERGIIKVGEEVEIVGI    223

gb_WP_0098878    251 TEAPRKVVVTGVEMFRKLLDQAQAGDNIGALLRGVQRNEIERGQVLAKTG    300
                     .|. :|...|||||||||||:.:||:|:|.||||::|.||||||||||.|
3u6b_A_mol_pr    224 KET-QKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPG    272

gb_WP_0098878    301 SVKAHTKFTAEVYVLKKEEGGRHTPFFDGYRPQFYFRTTDVTGACKLPEG    350
                     ::|.||||.:|||:|.|:|||||||||.|||||||||||||||..:||||
3u6b_A_mol_pr    273 TIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEG    322

gb_WP_0098878    351 IEMVMPGDNVTMEVDLINSIVVEEGLRFSIREGGRTVASGVVATIIE    397
                     :||||||||:.|.|.||:.|.:::||||:||||||||.:||||.::.
3u6b_A_mol_pr    323 VEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG    369


#---------------------------------------
#---------------------------------------